ArticleBlood advances2026

Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study.

Irene Dogliotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.